Research Grade Vofatamab (DHD52901)

Catalog No.

DHD52901

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

IgG1-kappa

Clonality

Monoclonal

Target

Fibroblast growth factor receptor 3, FGFR-3, FGFR3, JTK4, CD333

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P22607

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

MFGR1877S, MFGR-1877S, MFGR 1877S, CAS: 1312305-12-6

Clone ID

Vofatamab

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors, PMID: 31803255

[Innovations in systemic treatment of urothelial carcinoma], PMID: 32620209

Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma, PMID: 22203368

Document Download

Research Grade Vofatamab.pdf